| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.438 | 3.220 | 0 | 258 | 29.464 | 65.426 | 135.932 | 135.015 | 138.992 | 115.528 |
| Total Income - EUR | 10.438 | 3.220 | 0 | 258 | 29.464 | 65.448 | 135.977 | 135.109 | 139.100 | 118.695 |
| Total Expenses - EUR | 7.319 | 3.468 | 2.742 | 2.474 | 5.351 | 8.151 | 10.076 | 13.904 | 29.214 | 13.727 |
| Gross Profit/Loss - EUR | 3.118 | -248 | -2.742 | -2.217 | 24.112 | 57.297 | 125.901 | 121.205 | 109.887 | 104.969 |
| Net Profit/Loss - EUR | 2.805 | -345 | -2.742 | -2.224 | 23.818 | 56.683 | 124.541 | 119.854 | 108.496 | 101.408 |
| Employees | 3 | 0 | 0 | 0 | 1 | 1 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Acta Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.372 | 9.276 | 9.119 | 36.679 | 36.537 | 35.845 | 37.943 | 40.397 | 74.511 | 74.094 |
| Current Assets | 3.869 | 3.334 | 4 | 0 | 18.054 | 52.817 | 171.077 | 139.580 | 201.040 | 300.613 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 51 | 83 | 1 | 0 | 3.299 | 0 | 263 | 0 | 4.172 | 0 |
| Cash | 3.818 | 3.251 | 3 | 0 | 14.755 | 52.817 | 170.813 | 139.580 | 196.868 | 300.613 |
| Shareholders Funds | 13.089 | 12.610 | 7.965 | 5.595 | 29.304 | 85.432 | 208.078 | 166.354 | 274.346 | 111.241 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 152 | 0 | 1.158 | 31.084 | 25.287 | 3.230 | 942 | 13.622 | 1.205 | 263.467 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Acta Medica Srl